Cyanotech (Cyanotech) Debt-to-Equity

: 0.81 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

Cyanotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $6.33 Mil. Cyanotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $4.88 Mil. Cyanotech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $13.83 Mil. Cyanotech's debt to equity for the quarter that ended in Dec. 2023 was 0.81.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cyanotech's Debt-to-Equity or its related term are showing as below:

CYAN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.25 Med: 0.46 Max: 0.88
Current: 0.81

During the past 13 years, the highest Debt-to-Equity Ratio of Cyanotech was 0.88. The lowest was 0.25. And the median was 0.46.

CYAN's Debt-to-Equity is ranked worse than
71.68% of 1642 companies
in the Consumer Packaged Goods industry
Industry Median: 0.4 vs CYAN: 0.81

Cyanotech Debt-to-Equity Historical Data

The historical data trend for Cyanotech's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyanotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

0.55

0.79

0.62

0.44

0.68

Cyanotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.56	0.68	0.76	0.78	0.81

Competitive Comparison

For the Packaged Foods subindustry, Cyanotech's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyanotech Debt-to-Equity Distribution

For the Consumer Packaged Goods industry and Consumer Defensive sector, Cyanotech's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cyanotech's Debt-to-Equity falls into.

Cyanotech Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cyanotech's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.892	+	5.275)	/	16.347
	=	0.68

Cyanotech's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.326	+	4.883)	/	13.833
	=	0.81

Cyanotech (OTCPK:CYAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Cyanotech Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cyanotech's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyanotech (Cyanotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740

Website

https://www.cyanotech.com

Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.

Executives

Kakuk Collette Nicole	officer: Chief Strategic Comml Officer	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis	director, 10 percent owner	1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee	director	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann	officer: VP, Sales & Marketing	73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Glenn Jensen	officer: VP-Operations	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Jennifer M. Johansen	officer: VP of Quality	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel	director	45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin	officer: CFO, VP Fin & Admin, Treasurer	26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer	officer: Vice President, Gen Mgr	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin	officer: VP, HR, Secretary	73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp	officer: CFO, VP, Treasurer, Secretary	73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts	officer: COO	2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton	officer: President	7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz	director	CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder	director	21771 CALATRAVA, MISSION VIEJO CA 92692